Erratum: Association of metabolically healthy obesity with subclinical coronary atherosclerosis in a korean population(Obesity (2014) 22:2613-20. DOI: 10.1002/oby.20883);Association of metabolically healthy obesity with subclinical coronary atherosclerosis in a Korean population

Obesity

Volumn 22, Issue 12, 2014, Pages 2613-2620

  Jung, Chang Hee ^a   Lee, Min Jung ^a   Hwang, Jenie Yoonoo ^a   Jang, Jung Eun ^a   Leem, Jaechan ^a   Yang, Dong Hyun ^a   Kang, Joon Won ^a   Kim, Eun Hee ^a   Park, Joong Yeol ^a   Kim, Hong Kyu ^a   Lee, Woo Je ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM;

ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY CALCIUM SCORE; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; FEMALE; HEALTH STATUS; HUMAN; KOREAN (PEOPLE); MALE; METABOLICALLY HEALTHY OBESITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; OBESITY; ASIAN CONTINENTAL ANCESTRY GROUP; COMORBIDITY; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; MASS SCREENING; MIDDLE AGED; PREVALENCE; RADIOGRAPHY; RISK; RISK ASSESSMENT; RISK FACTOR; SOUTH KOREA; STATISTICS AND NUMERICAL DATA;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; COMORBIDITY; CORONARY ARTERY DISEASE; FEMALE; HEALTH STATUS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; OBESITY; ODDS RATIO; PLAQUE, ATHEROSCLEROTIC; PREVALENCE; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS;

EID: 84924954045     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21007     Document Type: Erratum

References (39)

1. Mokdad AH, Ford ES, Bowman BA, et al., Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76-79.
2. Phillips CM,. Metabolically healthy obesity: Definitions, determinants and clinical implications. Rev Endocr Metab Disord 2013; 14: 219-227.
3. Primeau V, Coderre L, Karelis AD, et al., Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond) 2011; 35: 971-981.
4. Stefan N, Kantartzis K, Machann J, et al., Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008; 168: 1609-1616.
5. Ruderman NB, Schneider SH, Berchtold P,. The "metabolically-obese," normal-weight individual. Am J Clin Nutr 1981; 34: 1617-1621.
6. Hinnouho GM, Czernichow S, Dugravot A, Batty GD, Kivimaki M, Singh-Manoux A,. Metabolically healthy obesity and risk of mortality: Does the definition of metabolic health matter? Diabetes Care 2013; 36: 2294-2300.
7. Hamer M, Stamatakis E,. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab 2012; 97: 2482-2488.
8. Calori G, Lattuada G, Piemonti L, et al., Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: The Cremona Study. Diabetes Care 2011; 34: 210-215.
9. Kramer CK, Zinman B, Retnakaran R,. Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann Intern Med 2013; 159: 758-769.
10. Khan UI, Wang D, Thurston RC, et al., Burden of subclinical cardiovascular disease in "metabolically benign" and "at-risk" overweight and obese women: The Study of Women's Health Across the Nation (SWAN). Atherosclerosis 2011; 217: 179-186.
11. Marini MA, Succurro E, Frontoni S, et al., Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women. Diabetes Care 2007; 30: 2145-2147.
12. Rhee EJ, Seo MH, Kim JD, et al., Metabolic health is more closely associated with coronary artery calcification than obesity. PLoS One 2013; 8: e74564.
13. Sung KC, Cha SC, Sung JW, So MS, Byrne CD,. Metabolically healthy obese subjects are at risk of fatty liver but not of pre-clinical atherosclerosis. Nutr Metab Cardiovasc Dis 2014; 24: 256-262.
14. Budoff MJ, Achenbach S, Blumenthal RS, et al., Assessment of coronary artery disease by cardiac computed tomography: A scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation 2006; 114: 1761-1791.
15. Lee SH, Baek S, Ahn SH, et al., Association between metabolic syndrome and incident fractures in korean men: A 3-year follow-up observational study using national health insurance claims data. J Clin Endocrinol Metab 2014; 99: 1615-1622.
16. American Diabetes Association. Standards of Medical Care in Diabetes-2013. Diabetes Care 2013; 36: S11-S66.
17. Furusyo N, Koga T, Ai M, et al., Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: Results from the Kyushu and Okinawa Population Study (KOPS). Diabetologia 2011; 54: 3028-3036.
18. Yeh ET, Willerson JT,. Coming of age of C-reactive protein: Using inflammation markers in cardiology. Circulation 2003; 107: 370-371.
19. Consultation WHOE. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163.
20. Wildman RP, Muntner P, Reynolds K, et al., The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: Prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008; 168: 1617-1624.
21. Ostrom MP, Gopal A, Ahmadi N, et al., Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography. J Am Coll Cardiol 2008; 52: 1335-1343.
22. Min JK, Shaw LJ, Devereux RB, et al., Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol 2007; 50: 1161-1170.
23. Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
24. Karelis AD, Rabasa-Lhoret R,. Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals. Diabetes Metab 2008; 34: 183-184.
25. Kuk JL, Ardern CI,. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care 2009; 32: 2297-2299.
26. Kip KE, Marroquin OC, Kelley DE, et al., Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: A report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation 2004; 109: 706-713.
27. Arnlov J, Ingelsson E, Sundstrom J, Lind L,. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2010; 121: 230-236.
28. van der AD, Nooyens AC, van Duijnhoven FJ, Verschuren MM, Boer JM,. All-cause mortality risk of metabolically healthy abdominal obese individuals: The EPIC-MORGEN study. Obesity (Silver Spring) 2014; 22: 557-564.
29. Waxman S, Ishibashi F, Muller JE,. Detection and treatment of vulnerable plaques and vulnerable patients: Novel approaches to prevention of coronary events. Circulation 2006; 114: 2390-2411.
30. Motoyama S, Sarai M, Harigaya H, et al., Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol 2009; 54: 49-57.
31. Velho S, Paccaud F, Waeber G, Vollenweider P, Marques-Vidal P,. Metabolically healthy obesity: Different prevalences using different criteria. Eur J Clin Nutr 2010; 64: 1043-1051.
32. Bluher M,. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol 2010; 21: 38-43.
33. Lind L, Siegbahn A, Ingelsson E, Sundstrom J, Arnlov J,. A detailed cardiovascular characterization of obesity without the metabolic syndrome. Arterioscler Thromb Vasc Biol 2011; 31: e27-34.
34. Park J, Kim SH, Cho GY, et al., Obesity phenotype and cardiovascular changes. J Hypertens 2011; 29: 1765-1772.
35. Wohlin M, Sundstrom J, Andren B, Larsson A, Lind L,. An echolucent carotid artery intima-media complex is a new and independent predictor of mortality in an elderly male cohort. Atherosclerosis 2009; 205: 486-491.
36. Schachinger V, Britten MB, Zeiher AM,. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899-1906.
37. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH,. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-352.
38. Phillips CM, Perry IJ,. Does inflammation determine metabolic health status in obese and nonobese adults? J Clin Endocrinol Metab 2013; 98: E1610-1619.
39. Karelis AD, Faraj M, Bastard JP, et al., The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005; 90: 4145-4150.